Abstract
Sulpyrid is a new psychoactive drug and several clinical studies indicate a series of polymorphic therapeutic indications.
Experimentally, sulpyrid blocks muricide reactions by isolation in rats but it is not active on aggressiveness in mice. Sulpyrid also modifies the exploratory activity in mice in which it decreases the brain 5-hydroxytryptamine turnover, as well as in rats.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bel, A.: Effets de la thiopropérazine, du sulpiride et de certaines anti-enzymes sur des lésions gastriques vasomotrices et hémorragiques expérimentales. J. méd. Lyon 1167, 1093–1095 (1969).
Benoit, J. C., Delagrange, G., Richou, A., Souchon, G., Sow, I., Sivadon, P.: Contribution a l'étude clinique d'un nouveau neuroleptique: le sulpiride. Sem. HÔp. Paris 45, 958–963 (1969).
Boissier, J. R., Simon, P., Lwoff, J.-M.: L'utilisation d'une réaction particulière de la souris (Méthode de la planche à trous) pour l'étude des medicaments psychotropes. Thérapie 19, 571–589 (1964).
Borenstein, P., Champion, C., Cujo, P., Gekière, F., Olivenstein, C., Kramarz, P.: Un psychotrope original: le sulpiride. Sem. HÔp. Paris 45, 1301–1314 (1969).
—, Cujo, P.: Electroencéphalographie clinique et substances psychotropes. Sem. HÔp. Paris 45, 1315–1330 (1969).
Boullin, D. J., O'Brien, R. A.: The binding of imipramine to the outer membrane of blood platelets. J. Pharm. Pharmacol. 20, 583–584 (1968).
Carlsson, A.: Pharmacological depletion of catecholamine stores. Pharmacol. Rev. 18, 541–549 (1966).
—, Jonason, J., Lindqvist, M., Fuxe, K.: Demonstration of extraneuronal 5-hydrotryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain Res. 12, 456–460 (1969).
Ciccarelli, G., Nosé, F.: Impiego della sulpiride in clinica psichiatrica (Nota preliminare). Settim. med. 59, 1–9 (1971).
Collard, J.: Le sulpiride, un neuroleptique singulier, anti-autistique et thymanaleptique. Thérapeutique 46, 503–506 (1970).
Garattini, S., Giacalone, E., Valzelli, L.: Isolation, aggressiveness and brain 5-hydroxytryptamine turnover. J. Pharm. Pharmacol. 19, 338–339 (1967).
Giacalone, E., Valzelli, L.: A spectrofluorometric method for the simultaneous determination of 2-(5-hydroxyindol-3yl) ethylamine (Serotonin) and 5-hydroxyindol-3yl-acetic acid in the brain. Pharmacology 2, 171–175 (1969).
Hukuhara, T., Nakayama, S., Neya, T.: Effects of N-(ethyl-2-pyrrolidinyl-methyl)-2-methoxy-5-sulfamoyl-benzamide (Sulpyrid) upon the gastrointestinal movements. Jap. J. Smooth Muscle Res. 5, 50–54 (1969).
Justin-BesanÇon, L., Thominet, M., Laville, C., Margarit, J.: Constitution chimique et propriétés biologiques du sulpiride. C. R. Acad. Sci. (Paris) 265, 1253–1254 (1967).
Katz, G.: Emploi du dogmatil dans la cure et la post-cure des états psychotiques et psychonévrotiques. Bordeaux méd. 5, 1403–1404 (1970).
Laverty, R., Taylor, K. M.: The fluorometric assay of catecholamines and related compounds; improvements and hydroxyindole technique. Analyt. Biochem. 22, 269–279 (1968).
Laville, C., Margarit, J.: Sur les effets neurologiques centraux du sulpiride. Path. et Biol. 17, 71–75 (1969).
Marmo, E., Caputi, A., Imperatore, A., Vuolo, L.: Ricerche sperimentali condotte con la sulpiride relativamente all'apparato cardiovascolare e alla muscolatura intestinale ed uterina. Gazz. int. Med. Chir. 76, 758–795 (1971).
Meek, J., Fuxe, K., Andén, N.-E.: Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission. Europ. J. Pharmacol. 9, 325–332 (1970).
Morel, P.: Premiers essais cliniques du sulpiride dans un service de psychiatrie générale. Ouest med. 22, 507–605 (1969).
Puyelo, R., Moreau, S., Miedzyrzecki, J.: Expérimentation du sulpiride en pédopsychiatrie. Sem. HÔp. Paris 46, 93–96 (1970).
Sokolov, E. N.: Higher nervous functions: the orienting reflex. Ann. Rev. Physiol. 25, 545–580 (1963).
Tozer, T. N., Neff, N. H., Brodie, B. B.: Application of steady state kinetics to the synthesis rate and turnover time of serotonin in the brain of normal and reserpine-treated rats. J. Pharmacol. exp. Ther. 153, 177–182 (1966).
Valzelli, L.: Drugs and aggressiveness. Advanc. Pharmacol. 5, 79–108 (1967).
—: The exploratory behaviour in normal and aggressive mice. Psychopharmacologia (Berl.) 15, 232–235 (1969).
—: Further aspects of the exploratory behavior in aggressive mice. Psychopharmacologia (Berl.) 19, 91–94 (1971a).
—: Agressivité chez le rat et la souris: aspects comportamentaux et biochimiques. Actualités pharmacol. 24, 133–152 (1971b).
—: Interazioni tra psicofarmaci diversi e psicofarmaci e substrato emotivo. In: Atti della Tavola Rotonda sulle Associazioni Psicofarmacologiche, “Il Ciocco”, Nov. 1970, pp. 62–74. Pisa: Pacini Mariotti 1971c.
—: Psychoactive drugs and brain neurochemical transmitters. Arch. int. Pharmacodyn. 196, 221–228 (1972).
—, Bernasconi, S.: Differential activity of some psychotropic drugs as a function of emotional level in animals. Psychopharmacologia (Berl.) 20, 91–96 (1971).
—, Giacalone, E., Garattini, S.: Pharmacological control of aggressive behavior in mice. Europ. J. Pharmacol. 2, 144–146 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valzelli, L., Bernasconi, S. Effects of N-(ethyl-2 pyrrolidinyl-methyl)-2-methoxy-5-sulfamoil-benzamide (sulpyrid) on the central nervous system in rats and mice. Psychopharmacologia 26, 255–261 (1972). https://doi.org/10.1007/BF00422701
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00422701